Cyclo-oxygenase (COX) enzymes are the targets for non-steroidal anti-inflammatory drugs (NSAIDs). These drugs demonstrate a variety of inhibitory mechanisms, which include simple competitive, as well as slow binding and irreversible inhibition. In general, most NSAIDs inhibit COX-1 and −2 by similar mechanisms. A unique class of diarylheterocyclic inhibitors has been developed that is highly selective for COX-2 by virtue of distinct inhibitory mechanisms for each isoenzyme. Several of these inhibitors, with varying selectivity, have been utilized to probe the mechanisms of COX inhibition. Results from analysis of both steady-state and time-dependent inhibition were compared. A generalized mechanism for inhibition, consisting of three sequential reversible steps, can account for the various types of kinetic behaviour observed with these inhibitors.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
August 2001
- PDF Icon PDF LinkFront Matter
Research Article|
July 25 2001
A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors
Mark C. WALKER;
Mark C. WALKER
1
Searle Discovery Research, Pharmacia Corp., 700 Chesterfield Parkway N., St Louis, MO 63198, U.S.A.
1To whom correspondence should be addressed (e-mail [email protected]).
Search for other works by this author on:
Ravi G. KURUMBAIL;
Ravi G. KURUMBAIL
Searle Discovery Research, Pharmacia Corp., 700 Chesterfield Parkway N., St Louis, MO 63198, U.S.A.
Search for other works by this author on:
James R. KIEFER;
James R. KIEFER
Searle Discovery Research, Pharmacia Corp., 700 Chesterfield Parkway N., St Louis, MO 63198, U.S.A.
Search for other works by this author on:
Kirby T. MORELAND;
Kirby T. MORELAND
Searle Discovery Research, Pharmacia Corp., 700 Chesterfield Parkway N., St Louis, MO 63198, U.S.A.
Search for other works by this author on:
Carol M. KOBOLDT;
Carol M. KOBOLDT
Searle Discovery Research, Pharmacia Corp., 700 Chesterfield Parkway N., St Louis, MO 63198, U.S.A.
Search for other works by this author on:
Peter C. ISAKSON;
Peter C. ISAKSON
Searle Discovery Research, Pharmacia Corp., 700 Chesterfield Parkway N., St Louis, MO 63198, U.S.A.
Search for other works by this author on:
Karen SEIBERT;
Karen SEIBERT
Searle Discovery Research, Pharmacia Corp., 700 Chesterfield Parkway N., St Louis, MO 63198, U.S.A.
Search for other works by this author on:
James K. GIERSE
James K. GIERSE
Searle Discovery Research, Pharmacia Corp., 700 Chesterfield Parkway N., St Louis, MO 63198, U.S.A.
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
January 18 2001
Revision Received:
April 09 2001
Accepted:
May 16 2001
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London ©2001
2001
Biochem J (2001) 357 (3): 709–718.
Article history
Received:
January 18 2001
Revision Received:
April 09 2001
Accepted:
May 16 2001
Citation
Mark C. WALKER, Ravi G. KURUMBAIL, James R. KIEFER, Kirby T. MORELAND, Carol M. KOBOLDT, Peter C. ISAKSON, Karen SEIBERT, James K. GIERSE; A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors. Biochem J 1 August 2001; 357 (3): 709–718. doi: https://doi.org/10.1042/bj3570709
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |